medigraphic.com
ISSN 0187-5337 (Print)
Instituto Nacional de Perinatología

2012, Number 2

<< Back Next >>

Perinatol Reprod Hum 2012; 26 (2)

Diagnostic approach of breast cancer in the National Institute of Perinatology

Sánchez-Ramírez B, Herrerías-Canedo T, Olaya-Guzmán EJ, Sequeira-Alvarado KA

Language: Spanish
References: 39
Page: 106-114
PDF size: 150.02 Kb.


ABSTRACT

The breast cancer is the first cause of death among cancers in Mexico, since 2006. Late diagnosis means that treatment is more expensive, painful, and has less chance of cure. Objective: Analyze the diagnostic approach done by the Instituto Nacional de Perinatología Isidro Espinosa de los Reyes. Material and methods: A retrolective, observational, descriptive, cross sectional study was done, from January 2004 to December 2010. 54 patients, between 29 to 85 years of age were studied. The most important symptom to request consultation was tumor of the mammary gland, with an evolution of 8.4 months. 84% of the cases had a palpable lesion. Mastography was done in 82.4% of the cases and ultrasound in 80.4%. The final diagnosis of breast cancer, was done through biopsy in an average of 3.8 months, and in 37% of the cases an intraoperatory study was done. The histological type most seen was the ductal infiltrative, in 67.4% of the cases. The stage at the time of diagnosis was II, in 46.3% of the cases. Comparing clinical staging with pathological tumor size and nodal agreed 64.7 and 59.5% respectively. Conclusions: Therefore the OB-GYN has a key role in addressing the diagnosis and treatment of breast diseases in women.


REFERENCES

  1. Maza-Fernández ME, Vecchi-Martini E. El cáncer de mama en México: evolución, panorama actual y retos de la sociedad civil. Salud Publica Mex 2009; 51: S329-34.

  2. López-Carrillo L, Torres-Sánchez L, López-Cervantes M, Rueda-Neria C. Identification of malignant breast lesions in Mexico. Salud Pública Mex 2001; 43: 199-202

  3. Instituto Nacional de Estadística y Geografía. Estadísticas a propósito del Día Mundial Contra el Cáncer. Datos nacionales. http://www.inegi.org.mx/inegi/contenidos/espanol/

  4. Kösters JP, Gøtzsche PC. Autoexamen o examen clínico regular para la detección precoz del cáncer de mama (Revisión Cochrane traducida). En: La Biblioteca Cochrane Plus. Número 2. Oxford: Update Software Ltd; 2008. Disponible en: http://www.update-software.com (Traducida de The Cochrane Library; 2008. Issue 2. Chichester, UK: John Wiley & Sons, Ltd.).

  5. Gøtzsche PC, Nielsen M. Cribaje (screening) con mamografía para el cáncer de mama (Revisión Cochrane traducida). En: La Biblioteca Cochrane Plus. Número 4. Oxford: Update Software Ltd; 2008. Disponible en: http://www.update-software.com (Traducida de The Cochrane Library; 2008. Issue 3. Chichester, UK: John Wiley & Sons, Ltd.).

  6. Conzen SD, Grushko TA, Olopade OI. Cancer of the breast. In: DeVita VT, Lawrence TS, Rosenberg S, editors. DeVita, Hellman & Rosenberg’s Cancer: Principles & Practices of Oncology. 8th ed. Philadelphia, PA: Lippincott, Williams & Wilkins; 2008:1595-1605.

  7. Singhal H, Lai LM, Teh W, Lewin JM, Coombs BD, Azavedo E et al. Breast, stereotactic core biopsy/fine needle aspiration. Updated Apr 22, 2010. Accessed Sep 9, 2010. Available at URL address: http://www.emedicine.com/radio/topic768.htm

  8. Porter P. Westernizing women’s risk? Breast cancer in lower-income countries. N Engl J Med 2008; 358: 213-216.

  9. Dirección General de Salud Reproductiva. Secretaría de Salud. Detección Oportuna de Cáncer Mamario. México, 2000.

  10. Dirección General de Estadística e Informática/Instituto Nacional de Estadística, Geografía e Informática (INEGI). Estadísticas vitales, series históricas. México, D.F. Secretaría de Salud, 1999. Disponible en: http://www.ssa.gob.mx/

  11. López-Ríos O, Lazcano-Ponce EC, Tovar-Guzmán V, Hernández-Ávila M. La epidemia de cáncer de mama en México. ¿Consecuencia de la transición demográfica? Salud Pública Mex 1997; 39: 259-265.

  12. Arkoob K, Al-Nsour M, Al-Nemry O, Al-Hajawi B. Epidemiology of breast Cancer in Jordan: patient characteristics and survival analysis. East Mediterr Health J 2010; 16: 1032-1038.

  13. Pollán M. Epidemiology of breast cancer in young women. Breast Cancer Res Treat 2010; 123S1: 3-6.

  14. Smigal C, Jemal A, Ward E, Cokkinides V, Smith R, Howe H, Thun M. Trends in Breast Cancer by Race and Ethnicity: Update 2006. CA Cancer J Clin 2006; 56: 168-183.

  15. The American College of Obstetricians and Gynecologist. Clinical Updates in Women’s Health Care. Continuing care for women with breast cancer. ACOG 2010; 2: 3-4.

  16. Nosarti C, Crayford T, Roberts J, Elias E, McKenzie K, David A. Delay in presentation of symptomatic referrals to a breast clinic: patient and system factors. Br J Cancer 2000; 82: 742-748.

  17. Facione N. Delay versus help seeking for breast cancer symptoms: a critical review of the literature on patient and provider delay. Soc Sci Med 1993; 36: 1521-1534.

  18. Knaul F, Nigenda G, Lozano R, Arreola H, Langer A, Frenk J. Cáncer de mama en México: una prioridad apremiante. Salud Pública Mex 2009; 51: S335-344.

  19. Secretaría de Salud. Programa de Acción: Cáncer de Mama. México: SS, 2002.

  20. American Cancer Society. Breast Cancer Facts & Figures 2007-2008. Atlanta; American Cancer Society, 2008. [Consultado el 20 de Febrero de 2011]. Disponible en: http://209.135.47.118/downloads/STT/BCFF-Final.pdf

  21. Calderón-Garcidueñas AL, Parás-Barrientos FU, Cárdenas-Ibarra L, González-Guerrero JF, Villarreal-Ríos E, Staines-Boone T et al. Risk factors of breast cancer in Mexican women. Salud Pública Mex 2000; 42: 26-33.

  22. Instituto Nacional de Salud Pública y Secretaría de Salud. Encuesta Nacional de Salud, ENSANUT2000. Vivienda, población y utilización de servicios de salud. Cuernavaca: INSP, 2003.

  23. Instituto Nacional de Salud Pública. Encuesta Nacional de Salud y Nutrición, ENSANUT 2006. Cuernavaca: INSP, 2007.

  24. López-Carrillo L, Suárez-López L, Torres-Sánchez L. Detección del cáncer de mama en México: síntesis de los resultados de la Encuesta Nacional de Salud Reproductiva. Salud Pública Mex 2009; 51: S345-349.

  25. American Cancer Society. Breast cancer facts & figures 2009-2010. Dallas (TX): ACS; 2009. Disponible en: http://www.cancer.org/downloads/STT/F861009_final%209-08-09.pdf. Retrieved: October 23, 2009.

  26. Janzon L, Andersson I. The Malmo mammographic screening trial. In: Miller AB: Chamberlain J, Day NE et al, eds. Cancer Screening. Cambridge: Cambridge University Press, 1991: 37-44.

  27. Moody-Ayers SY, Wells CK, Feinstein AR. “Benign” tumors and “early detection” in mammography-screened patients of a natural cohort with breast cancer. Arch Intern Med 2000; 160: 1109-1115.

  28. American College of Radiology. BI-RADS– mammography: assessment categories. En: ACR breast imaging reporting and data systems, breast imaging atlas. 4 ed. Reston (VA): American College of Radiology; 2003: 193-198.

  29. Lazarus E, Mainiero M, Schepps B, Koelliker S, Livingston L. BI-RADS lexicon for US and mammography: interobserver variability and positive predictive value. Radiology 2006; 239: 385-391.

  30. Ghosh K, Melton III J, Suman V, Grant C, Sterioff S. Brandt K et al. Breast biopsy utilization. Arch Intern Med 2005; 165: 1593-1598.

  31. Rogers L. Breast Biopsy: A Pathologist’s Perspective on Biopsy Acquisition Techniques and Devices with Mammographic–Pathologic Correlation. Semin Breast Dis 2005; 8: 127-137.

  32. Silverstein MJ, Lagios MD, Recht A, Allred DC, Harms SE, Holland R et al. Image-detected breast cancer: state of the art diagnosis and treatment. J Am Coll Surg 2005; 201: 586-597.

  33. Albrektsen G, Heuch I, Thoresen SO. Histological type and grade of breast cancer tumors by parity, age at birth, and time since birth: a register-based study in Norway. Cancer 2010; 10: 226-236.

  34. Li C, Moe R, Daling JR. Risk of mortality by histologic type of breast cancer among women aged 50 to 79 years. Arch Intern Med 2003; 163: 2149-2153.

  35. Feig SA. Ductal carcinoma in situ. Radiol Clin N Am 2000; 38: 653-668.

  36. Vameşu S. Angiogenesis and tumor histologic type in primary breast cancer patients: an analysis of 155 needle core biopsies. Rom J Morphol Embryol 2008; 49: 181-188.

  37. Rizo P, Sierra M, Vázquez G, Cano M, Meneses A, Mohar A. Registro hospitalario de cáncer 2000-2004. Cancerología 2007; 2: 203-287.

  38. Mainero RFE, Aguilar GUI, Bernechea MA, Vargas SJM, Burgos PI. Edad, etapa clínica y tipo histológico del carcinoma mamario en la Gineco 4. IMSS. Rev Mex Mastol 2008; 3: 57-60.

  39. Norma Oficial Mexicana NOM-041-SSA2-2011, para la prevención, diagnóstico, tratamiento, control y vigilancia epidemiológica del cáncer de mama.




2020     |     www.medigraphic.com